x

This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 




Myriad patent suit enters antitrust territory

08-08-2013

Myriad patent suit enters antitrust territory

Ambry Genetics, the laboratory sued last month by biotech company Myriad over patents covering the BRCA1 and BRCA2 genes, has hit back with antitrust claims.


ambry genetics, myriad genetics, brca1, brca2, prometheus

WIPR

Payment types accepted